Xolair for s.c. injection 75mg syringe (ゾレア皮下注75mgシリンジ) Jepun - Inggeris - すりの適正使用協議会 RAD-AR Council, Japan

xolair for s.c. injection 75mg syringe (ゾレア皮下注75mgシリンジ)

novartis pharma k.k. - omalizumab (genetical recombination) - injection

Actair 100 IR & 300 IR Initiation treatment sublingual tablets New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

actair 100 ir & 300 ir initiation treatment sublingual tablets

stallergenes greer new zealand ltd - dermatophagoides farinae allergen extract 50 ir ((american house dust mite)); dermatophagoides pteronyssinus allergen extract 50 ir ((european house dust mite)); dermatophagoides farinae allergen extract 150 ir ((american house dust mite)); dermatophagoides pteronyssinus allergen extract 150 ir ((dermatophagoides pteronyssinus)) - sublingual tablet - 100ir & 300ir - active: dermatophagoides farinae allergen extract 50 ir ((american house dust mite)) dermatophagoides pteronyssinus allergen extract 50 ir ((european house dust mite)) excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose active: dermatophagoides farinae allergen extract 150 ir ((american house dust mite)) dermatophagoides pteronyssinus allergen extract 150 ir ((dermatophagoides pteronyssinus)) excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - actair is indicated for the treatment of house dust mite allergic rhinitis with or without conjunctivitis in adults, adolescents and children 5 years and over diagnosed with house dust mite allergy.

Actair 300 IR Continuation treatment sublingual tablets New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

actair 300 ir continuation treatment sublingual tablets

stallergenes greer new zealand ltd - dermatophagoides farinae allergen extract 150 ir ((american house dust mite)); dermatophagoides pteronyssinus allergen extract 150 ir ((european house dust mite)) - sublingual tablet - 300 ir - active: dermatophagoides farinae allergen extract 150 ir ((american house dust mite)) dermatophagoides pteronyssinus allergen extract 150 ir ((european house dust mite)) excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - actair is indicated for the treatment of house dust mite allergic rhinitis with or without conjunctivitis in adults, adolescents and children 5 years and over diagnosed with house dust mite allergy.

Oralair 100IR & 300IR sublingual tablets Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

oralair 100ir & 300ir sublingual tablets

stallergenes - grass pollen allergen extract - sublingual tablet - 100/300 index of reactivity - allergen extracts; grass pollen

Oralair 300 IR sublingual tablets Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

oralair 300 ir sublingual tablets

stallergenes - grass pollen allergen extract - sublingual tablet - 300 index of reactivity - allergen extracts; grass pollen

ACTAIR Continuation Treatment 300IR sublingual tablets blister pack Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

actair continuation treatment 300ir sublingual tablets blister pack

stallergenes australia pty ltd - european house dust mite, quantity: 150 ir; american house dust mite, quantity: 150 ir - tablet - excipient ingredients: magnesium stearate; croscarmellose sodium; lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; mannitol - treatment of house dust mite allergic rhinitis with or without conjunctivitis in adults, adolescents and children 5 years and over diagnosed with house dust mite allergy.

ACTAIR Initiation Treatment 100IR & 300IR sublingual tablets blister pack Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

actair initiation treatment 100ir & 300ir sublingual tablets blister pack

stallergenes australia pty ltd - european house dust mite, quantity: 150 ir; american house dust mite, quantity: 150 ir - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; lactose monohydrate; magnesium stearate; mannitol - treatment of house dust mite allergic rhinitis with or without conjunctivitis in adults, adolescents and children 5 years and over diagnosed with house dust mite allergy.

ACTAIR 100 IR & 300 IR sublingual tablets Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

actair 100 ir & 300 ir sublingual tablets

stallergenes - dermatophagoides pteronyssinus extract; dermatophagoides farinae extract - sublingual tablet - 100 & 300 index of reactivity - house dust mites

ACTAIR 100 IR sublingual tablets Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

actair 100 ir sublingual tablets

stallergenes - dermatophagoides pteronyssinus extract; dermatophagoides farinae extract - sublingual tablet - 100 index of reactivity - house dust mites

ACTAIR 300 IR sublingual tablets Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

actair 300 ir sublingual tablets

stallergenes - dermatophagoides pteronyssinus extract; dermatophagoides farinae extract - sublingual tablet - 300 index of reactivity - house dust mites